InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
20%
T+90 mean return
-20.3%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kidron Miriam, Directeur Scientifique. Director active across 1 company, notably Oramed Pharmaceuticals INC.. In total, 12 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €187k. History available since 14 March 2023. The latest transaction was filed on 11 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
74,000 shares0Common StockSEC:0001213900-25-012241:0
207,000 sharesCommon StockSEC:0001213900-25-001169:0
30,000 sharesCommon StockSEC:0001213900-24-095930:0
295,500 sharesCommon StockSEC:0001209191-24-001154:0
53,500 sharesCommon StockSEC:0001209191-23-033143:0
213,000 sharesCommon StockSEC:0001209191-23-024937:0
100,000 shares@ US$2.01100.0% of flowCommon StockSEC:0001209191-23-018952:0
34,000 sharesCommon StockSEC:0001209191-22-043769:0
42,000 sharesCommon StockSEC:0001213900-22-000816:0
42,000 sharesCommon StockSEC:0001213900-22-000816
66,666 sharesCommon StockSEC:0001213900-21-046411
66,666 sharesCommon StockSEC:0001213900-21-046411:0
12 of 12 declarations
About Kidron Miriam
Miriam Kidron is the Chief Scientific Officer at Oramed Pharmaceuticals Inc. She is responsible for the company's research and development strategy. Her role includes overseeing scientific projects and innovation in the pharmaceutical field. Through her expertise, she contributes to product advancement and Oramed's leading position in the market.
